Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:02 PM
Ignite Modification Date:
2025-12-25 @ 12:19 PM
NCT ID:
NCT00412061
Group ID:
EG001
Title:
Placebo + Octreotide
Description:
Matching placebo was administered in accordance with a 10-mg daily dosing regimen (two 5-mg tablets) in conjunction with octreotide 30 mg intramuscularly (i.m.) every 28 days. Patients were treated until progression or unacceptable toxicity; Each treatment cycle lasted 28 days. Patients received their first dose of matching placebo at Cycle 1, Day 1. Administration of octreotide was performed every 28 days (± 4 days) starting on Cycle 1 Day 1.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
74
Serious Number At Risk:
211
Other Number Affected:
194
Other Number At Risk:
211
Study:
NCT00412061
Results Section:
NCT00412061
Adverse Events Module:
NCT00412061